Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SUVEN PHARMACEUTICALS LTD.

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE1108.2552.7 (+4.99 %)

PREV CLOSE ( ) 1055.55

OPEN PRICE ( ) 1046.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8737

TODAY'S LOW / HIGH ( )1046.00 1146.15

52 WK LOW / HIGH ( )586.1 1359

NSE1104.9050.15 (+4.75 %)

PREV CLOSE( ) 1054.75

OPEN PRICE ( ) 1056.95

BID PRICE (QTY) 1104.90 (23)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 154325

TODAY'S LOW / HIGH( ) 1053.65 1147.10

52 WK LOW / HIGH ( )585.2 1360

TRENDS

Particulars	Dec 2024	Sep 2024	Var%	Jun 2024	Mar 2024	Var%
Promoter and Promoter Group
Indian Promoters
Individuals / Hindu Undivided Family
Central Government/State Government(s)
Bodies Corporate
Financial Institutions / Banks
Partnership Firms
Promoter Group
Employees Welfare Fund
Other
Any Others (Specify)
Foreign Promoters	50.1	50.1	0	50.1	50.1	0
Non-Residents Individuals / Foreign Individuals
'Bodies Corporate
Institutions
Other	50.1	50.1	0	50.1	50.1	0
Any Others (Specify)
Total of Promoter and Promoter Group	50.1	50.1	0	50.1	50.1	0
Public Shareholding
Institutions	27.53	27.65	0.43	27.23	26.79	0.16
Mutual Funds / UTI	13.15	14.12	6.87	14.78	15.26	0.31
Financial Institutions / Banks
Insurance Companies	3.2	2.53	26.48	2.09	1.57	3.31
Foreign Institutional Investors
Venture Capital Funds
Foreign Venture Capital Investors
Alternate Investment Funds	0.32	0.3	6.67	0.55	0.41	3.41
Foreign Portfolio investors	10.84	10.7	1.31	9.8	9.54	0.27
Provident funds / Pension funds
Multilateral & Bileteral Development Financial Institution
Any Others (Specify)
Central Government / State Government(s)	0.01	0.01	0	0.01	0.01	0
Foreign Financial Institutions / Banks
Stressed Assets Stabilisation Fund
Foreign Financial Institutions
State Finance Corporation
Foreign Bodies DR
Other
Non-Institutions	22.37	22.25	0.54	22.67	23.1	0.19
Bodies Corporate	11.17	11.08	0.81	11.15	11.1	0.05
Individuals
Individual shareholders holding nominal share capital up to Rs. 1 lakh	9.53	9.48	0.53	9.79	10.23	0.43
Individual shareholders holding nominal share capital in excess of Rs. 1 lakh	0.28	0.28	0	0.28	0.28	0
NBFCs Registed with RBI
Employee Trusts
Any Others (Specify)
Clearing Members		0.03	100	0.02
Non Resident Indians	0.94	0.94	0	0.96	0.97	0.1
Directors & their Relatives & Friends
Foreign Collaborators
Foreign Mutual Fund
Trusts					0.02	10
Hindu Undivided Families	0.31	0.31	0	0.34	0.37	0.81
Foreign Corporate Bodies
Shares in transit
Market Maker
ESOP/ESOS/ESPS
Societies
Escrow Account
Any Other	0.14	0.14	0	0.14	0.14	0
Total Public Shareholding	49.9	49.9	0	49.9	49.9	0

Total of Promoter and Public Shareholding	100	100	0	100	100	0

Shares held by Custodians and against which Depository Receipts have been issued
American Depository Receipts
GDRs
Others

Grand Total	100	100	0	100	100	0

Risk Disclosures on Derivatives

Share Holdings

SUVEN PHARMACEUTICALS LTD.